Literature DB >> 33907947

The functional activity of the miR-1914-5p in lipid metabolism of the hepatocarcinoma cell line HepG2: a potential molecular tool for controlling hepatic cellular migration.

Marina Bonfogo da Silveira1, Camila Cristiane Pansa1, Osmar Malaspina2, Karen C M Moraes3.   

Abstract

Hepatocellular carcinoma is one of the most common types of cancer in the world with high mortality rate and new therapies that control of fatty acid metabolism may limit the proliferation of cancer cells. In the last two decades, the non-coding RNAs have been considered as promising molecular tools to treat diseases, because they are able to modulate gene expression and the metabolic routes; however, deep investigation of their mechanistic behavior in pathologies must be performed. Thus, our aim was to evaluate the modulatory effect of the miR-1914-5p in controlling lipid metabolism in HepG2, a widely used human hepatocarcinoma cell line. The molecular and cellular analyses demonstrated that the functional inhibition of the investigated microRNA completely changed the cellular metabolism and behavior, compared to control groups. The in vitro inhibition of the miR-1914-5p increased the energy expenditure pointed in different analyses, decreasing cell doubling time and migration rate verified in wound healing and in the classical transwell chambers invasion assays, which makes the miR-1914-5p a candidate for further translational and preclinical studies to validate its function in controlling metastasis in liver cancer or even treat those diseases.

Entities:  

Keywords:  Cell migration; Cellular mechanisms; Hepatic disease; Lipid metabolism; Non-coding RNAs; Systems biology

Year:  2021        PMID: 33907947     DOI: 10.1007/s11033-021-06364-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

1.  MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

Authors:  Mick D Edmonds; Kelli L Boyd; Tamara Moyo; Ramkrishna Mitra; Robert Duszynski; Maria Pia Arrate; Xi Chen; Zhongming Zhao; Timothy S Blackwell; Thomas Andl; Christine M Eischen
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

2.  Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis.

Authors:  Kuei-Yang Hsiao; Ya-Chi Lin; Sachin Kumar Gupta; Ning Chang; Laising Yen; H Sunny Sun; Shaw-Jenq Tsai
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

Review 3.  Cellular fatty acid metabolism and cancer.

Authors:  Erin Currie; Almut Schulze; Rudolf Zechner; Tobias C Walther; Robert V Farese
Journal:  Cell Metab       Date:  2013-06-20       Impact factor: 27.287

Review 4.  Aberrant lipid metabolism as a therapeutic target in liver cancer.

Authors:  Evans D Pope; Erinmarie O Kimbrough; Lalitha Padmanabha Vemireddy; Phani Keerthi Surapaneni; John A Copland; Kabir Mody
Journal:  Expert Opin Ther Targets       Date:  2019-05-10       Impact factor: 6.902

Review 5.  The Role of Non-coding RNAs in Oncology.

Authors:  Frank J Slack; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

Review 6.  Hepatocellular carcinoma: a review.

Authors:  Julius Balogh; David Victor; Emad H Asham; Sherilyn Gordon Burroughs; Maha Boktour; Ashish Saharia; Xian Li; R Mark Ghobrial; Howard P Monsour
Journal:  J Hepatocell Carcinoma       Date:  2016-10-05

Review 7.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

8.  Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.

Authors:  Yuan Jiang; Yan-Yi Jiang; Jian-Jun Xie; Anand Mayakonda; Masaharu Hazawa; Li Chen; Jin-Fen Xiao; Chun-Quan Li; Mo-Li Huang; Ling-Wen Ding; Qiao-Yang Sun; Liang Xu; Deepika Kanojia; Maya Jeitany; Jian-Wen Deng; Lian-Di Liao; Harmik J Soukiasian; Benjamin P Berman; Jia-Jie Hao; Li-Yan Xu; En-Min Li; Ming-Rong Wang; Xin-Gang Bi; De-Chen Lin; H Phillip Koeffler
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

9.  Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.

Authors:  Rui Zheng; Mulong Du; Xiaowei Wang; Weidong Xu; Jiayuan Liang; Wenying Wang; Qiang Lv; Chao Qin; Haiyan Chu; Meilin Wang; Lin Yuan; Jing Qian; Zhengdong Zhang
Journal:  Mol Cancer       Date:  2018-10-03       Impact factor: 27.401

10.  The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism.

Authors:  Shuangyan Ye; Pengfei Xu; Mengqiu Huang; Xi Chen; Sisi Zeng; Qianli Wang; Jianping Chen; Keyi Li; Wenwen Gao; Ruiyuan Liu; Jingxian Liu; Yihao Shao; Hui Zhang; Yang Xu; Qianbing Zhang; Zhuo Zhong; Zibo Wei; Jiale Wang; Bingtao Hao; Wenhua Huang; Qiuzhen Liu
Journal:  Cell Death Dis       Date:  2020-05-04       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.